{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:41Z","timestamp":1792097321787,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hoc.2026.09.010","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:39:44Z","timestamp":1792096784000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Approach to Thrombocytopenia"],"prefix":"10.1016","author":[{"given":"Tarinee","family":"Rungjirajittranon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cuker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054289","article-title":"Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data","volume":"8","author":"Biino","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.hoc.2026.09.010_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.annepidem.2005.06.052","article-title":"Platelet counts differ by sex, ethnicity, and age in the United States","volume":"16","author":"Segal","year":"2006","journal-title":"Ann Epidemiol"},{"issue":"9","key":"10.1016\/j.hoc.2026.09.010_bib3","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.3324\/haematol.2015.127597","article-title":"Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia","volume":"100","author":"Zaninetti","year":"2015","journal-title":"Haematologica"},{"issue":"26","key":"10.1016\/j.hoc.2026.09.010_bib4","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1182\/blood-2016-09-693655","article-title":"How I evaluate and treat thrombocytopenia in the intensive care unit patient","volume":"128","author":"Greinacher","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2026.09.010_bib5","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.010_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030024","article-title":"Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia","volume":"3","author":"Stasi","year":"2006","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.010_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.hoc.2019.01.008","article-title":"Inherited platelet disorders: a modern approach to evaluation and treatment","volume":"33","author":"Lambert","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"10.1016\/j.hoc.2026.09.010_bib8","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/jth.15368","article-title":"Definition of a critical bleed in patients with immune thrombocytopenia: communication from the ISTH SSC subcommittee on platelet immunology","volume":"19","author":"Sirotich","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3343\/alm.2013.33.1.1","article-title":"Purpose and criteria for blood smear scan, blood smear examination, and blood smear review","volume":"33","author":"Gulati","year":"2013","journal-title":"Ann Lab Med"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2257.2006.00870.x","article-title":"Spurious counts and spurious results on haematology analysers: a review. Part I: platelets","volume":"29","author":"Zandecki","year":"2007","journal-title":"Int J Lab Hematol"},{"issue":"8","key":"10.1016\/j.hoc.2026.09.010_bib11","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3324\/haematol.2024.286234","article-title":"Pseudothrombocytopenia and other conditions associated with spuriously low platelet counts","volume":"110","author":"Cattaneo","year":"2025","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.010_bib12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3390\/jcm9030808","article-title":"Platelet counting: ugly traps and good advice. Proposals from the french-speaking cellular hematology group (GFHC)","volume":"9","author":"Baccini","year":"2020","journal-title":"J Clin Med"},{"issue":"24","key":"10.1016\/j.hoc.2026.09.010_bib13","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.3390\/jcm14248765","article-title":"Postoperative thrombocytopenia in cardiac surgery: patterns, differential diagnosis and management of heparin-induced thrombocytopenia (HIT)","volume":"14","author":"Ampatzidou","year":"2025","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.athoracsur.2019.10.039","article-title":"Thrombocytopenia after cardiopulmonary bypass is associated with increased morbidity and mortality","volume":"110","author":"Griffin","year":"2020","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.hoc.2026.09.010_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2281653","article-title":"Postoperative thrombocytopenia and subsequent consequences in acute type A aortic dissection","volume":"55","author":"Tang","year":"2023","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.hoc.2026.09.010_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/bloodadvances.2019001414","article-title":"A practical approach to evaluating postoperative thrombocytopenia","volume":"4","author":"Skeith","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2018.09.041","article-title":"Blood disorders in patients undergoing transcatheter aortic valve replacement: a review","volume":"12","author":"De Larochelli\u00e8re","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.hoc.2026.09.010_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.recesp.2024.08.004","article-title":"Thrombocytopenia after transcatheter aortic valve implantation","volume":"78","author":"Tirado-Conte","year":"2025","journal-title":"Rev Esp Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2026.09.010_bib19","article-title":"Thrombocytopenia following implantation of different types of bioprosthetic aortic valves in severe aortic valve stenosis replacement","volume":"43","author":"Lampropoulos","year":"2022","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.hoc.2026.09.010_bib20","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","article-title":"Heparin-induced thrombocytopenia","volume":"129","author":"Arepally","year":"2017","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.hoc.2026.09.010_bib21","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American society of hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.hoc.2026.09.010_bib22","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/jth.14587","article-title":"The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia","volume":"17","author":"Pishko","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12959-025-00791-z","article-title":"Bleeding and thrombotic events in patients with heparin-induced thrombocytopenia: a two-decade single-center experience in Thailand","volume":"23","author":"Chantarawichian","year":"2025","journal-title":"Thromb J"},{"issue":"4","key":"10.1016\/j.hoc.2026.09.010_bib24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/hematology.2024000566","article-title":"Practical guide to the diagnosis and management of heparin-induced thrombocytopenia","volume":"2024","author":"May","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.010_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2796.1999.00527.x","article-title":"Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases","volume":"246","author":"Kadidal","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.hoc.2026.09.010_bib27","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.951331","article-title":"Bilateral adrenal infarction as an uncommon complication of heparin-induced thrombocytopenia: a case report","volume":"27","author":"Singla","year":"2026","journal-title":"Am J Case Rep"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2023000503","article-title":"Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond","volume":"2023","author":"Greinacher","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.hoc.2026.09.010_bib29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2021.05.018","article-title":"Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia","volume":"204","author":"Warkentin","year":"2021","journal-title":"Thromb Res"},{"issue":"21","key":"10.1016\/j.hoc.2026.09.010_bib30","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.3390\/jcm12216921","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"12","author":"Warkentin","year":"2023","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.010_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-0039-1697930","article-title":"Drug-induced thrombocytopenia: mechanisms and laboratory diagnostics","volume":"46","author":"Danese","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.hoc.2026.09.010_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1088031","article-title":"Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management","volume":"13","author":"Mazzierli","year":"2023","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.hoc.2026.09.010_bib33","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa065066","article-title":"Vancomycin-induced immune thrombocytopenia","volume":"356","author":"Von","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.hoc.2026.09.010_bib34","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1592\/phco.21.11.1010.34517","article-title":"Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid","volume":"21","author":"Kuter","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.hoc.2026.09.010_bib35","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.bcp.2007.06.047","article-title":"Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells","volume":"74","author":"Chang","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.hoc.2026.09.010_bib36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1538-7836.2009.03360.x","article-title":"Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management","volume":"7","author":"Aster","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hoc.2026.09.010_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.hoc.2026.09.010_bib38","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fphar.2019.00454","article-title":"Hematological side effects of immune checkpoint inhibitors: the example of immune-related thrombocytopenia","volume":"10","author":"Calvo","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hoc.2026.09.010_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/asheducation-2009.1.153","article-title":"Drug-induced thrombocytopenia: pathogenesis, evaluation, and management","author":"George","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.hoc.2026.09.010_bib40","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/jth.12852","article-title":"Platelet immunology scientific subcommittee of the international society on thrombosis and hemostasis. Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH","volume":"13","author":"Arnold","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.hoc.2026.09.010_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3810\/hp.2014.10.1151","article-title":"Hospital-acquired thrombocytopenia","volume":"42","author":"McMahon","year":"2014","journal-title":"Hosp Pract"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.010_bib42","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3109\/0886022X.2015.1057799","article-title":"The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients","volume":"37","author":"Ferreira","year":"2015","journal-title":"Ren Fail"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.010_bib43","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1159\/000517232","article-title":"Platelet decreases following continuous renal replacement therapy initiation as a novel risk factor for renal nonrecovery","volume":"51","author":"Griffin","year":"2022","journal-title":"Blood Purif"},{"issue":"4","key":"10.1016\/j.hoc.2026.09.010_bib44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/09537104.2021.1961707","article-title":"Severe thrombocytopenia in adults undergoing extracorporeal membrane oxygenation is predictive of thrombosis","volume":"33","author":"Kohs","year":"2022","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13054-025-05569-3","article-title":"Incidence, kinetics, and clinical impact of thrombocytopenia in venovenous ECMO: insights from the multicenter observational PROTECMO study","volume":"29","author":"Buchtele","year":"2025","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.hoc.2026.09.010_bib46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/CIRCRESAHA.123.322752","article-title":"Shear forces induced platelet clearance is a new mechanism of thrombocytopenia","volume":"133","author":"Rauch","year":"2023","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.hoc.2026.09.010_bib47","first-page":"123","article-title":"Incidence, predictors, and prognosis of thrombocytopenia among patients undergoing intra-aortic balloon pumping in the intensive care unit: a propensity score analysis","volume":"18","author":"Tong","year":"2021","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.hoc.2026.09.010_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.thromres.2016.02.022","article-title":"Sepsis-associated thrombocytopenia","volume":"141","author":"Larkin","year":"2016","journal-title":"Thromb Res"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.010_bib49","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jtha.2025.03.038","article-title":"Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC subcommittee on disseminated intravascular coagulation","volume":"23","author":"Iba","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.1016\/j.hoc.2026.09.010_bib50","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1111\/jth.14946","article-title":"Underlying disorders of disseminated intravascular coagulation: communication from the ISTH SSC subcommittees on disseminated intravascular coagulation and perioperative and critical care thrombosis and hemostasis","volume":"18","author":"Squizzato","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.hoc.2026.09.010_bib51","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.jtha.2025.04.033","article-title":"Mortality, diagnosis, and etiology of disseminated intravascular coagulation-a systematic review and meta-analysis: communication from the ISTH SSC subcommittee on disseminated intravascular coagulation","volume":"23","author":"Umemura","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.hoc.2026.09.010_bib52","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.103323","article-title":"Clinical characteristics of thrombocytopenia in tropical diseases and management in resource-limited settings","volume":"10","author":"Gurumurthy","year":"2026","journal-title":"Res Pract Thromb Haemost"},{"issue":"10","key":"10.1016\/j.hoc.2026.09.010_bib54","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.hoc.2026.09.010_bib55","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American society of hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.010_bib56","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/ijms23031296","article-title":"Therapeutic strategies for disseminated intravascular coagulation associated with aortic aneurysm","volume":"23","author":"Yamada","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hoc.2026.09.010_bib57","article-title":"Management of chronic disseminated intravascular coagulation associated with aortic aneurysm\/dissection","volume":"2019","author":"Koba","year":"2019","journal-title":"Case Rep Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2026.09.010_bib58","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/jama.2025.3807","article-title":"Immune thrombotic thrombocytopenic purpura: a review","volume":"334","author":"Pishko","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib59","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/asheducation-2018.1.530","article-title":"Clinical and laboratory diagnosis of TTP: an integrated approach","volume":"2018","author":"Chiasakul","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4274\/tjh.2016.0359","article-title":"The clinical significance of schistocytes: a prospective evaluation of the international council for standardization in hematology schistocyte guidelines","volume":"34","author":"Schapkaitz","year":"2017","journal-title":"Turk J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.010_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102654","article-title":"Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis","volume":"9","author":"Mahmoud","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"10","key":"10.1016\/j.hoc.2026.09.010_bib62","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.hoc.2026.09.010_bib63","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3390\/cancers16081462","article-title":"The challenge for a correct diagnosis of refractory thrombocytopenia: ITP or MDS with isolated thrombocytopenia?","volume":"16","author":"Kosmidou","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.hoc.2026.09.010_bib64","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1007\/s00277-025-06374-2","article-title":"An unconquered challenge in MDS: review of pathophysiology, clinical manifestations, and management options of MDS with thrombocytopenia","volume":"104","author":"Chen","year":"2025","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.010_bib65","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41375-023-01819-x","article-title":"Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries","volume":"37","author":"Liapis","year":"2023","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.hoc.2026.09.010_bib66","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.3390\/jcm11092596","article-title":"Myelodysplastic syndromes with isolated 20q deletion: a new clinical-biological entity?","volume":"11","author":"Campagna","year":"2022","journal-title":"J Clin Med"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858826001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858826001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:39:51Z","timestamp":1792096791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858826001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":66,"alternative-id":["S0889858826001206"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2026.09.010","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to Thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2026.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}